{"text": "the waxing and waning of the speedy approval via amp as the fda cools on the accelerated pathway could biopharmas annual approval count take a hit azn bmy jnj mrk nvs pfe abbv bayry"}
{"text": "nwbo similar to keytruda opdivo loses patent exclusivity in 2028 bmy vs mrk both in need of something to preserve their s"}
{"text": "3m bmy trial suddenly goes live nwbo mrk oncoloogy"}
{"text": "the trial appears to be indeed moving forward with the official start date expected within the next two weeks nwbo bmy oncology mrk"}
{"text": "nwbo bmy find out by jun 1"}
{"text": "abbv azn bayry bmy jnj mrk mkkgy nvs pfe the waxing and waning of the speedy approval"}
